Hartford Investment Management Co (HIMCO)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,924
Closed -$357K 508
2023
Q3
$357K Sell
3,924
-868
-18% -$76.5K 0.01% 501
2023
Q2
$388K Sell
4,792
-3,246
-40% -$265K 0.01% 502
2023
Q1
$640K Hold
8,038
0.02% 479
2022
Q4
$544K Sell
8,038
-104
-1% -$6.1K 0.02% 495
2022
Q3
$406K Sell
8,142
-1,490
-15% -$79.8K 0.01% 524
2022
Q2
$537K Sell
9,632
-1,686
-15% -$93.6K 0.02% 500
2022
Q1
$628K Hold
11,318
0.02% 502
2021
Q4
$634K Hold
11,318
0.01% 504
2021
Q3
$543K Hold
11,318
0.02% 509
2021
Q2
$474K Hold
11,318
0.01% 517
2021
Q1
$382K Hold
11,318
0.01% 516
2020
Q4
$395K Hold
11,318
0.01% 509
2020
Q3
$393K Hold
11,318
0.01% 495
2020
Q2
$371K Buy
+11,318
New +$361K 0.01% 499

Other funds holding NVO

Hartford Investment Management Co (HIMCO)'s NVO Position: Q4 2023 in Review

Hartford Investment Management Co (HIMCO) sold out of Novo Nordisk (NVO) in Q4 2023, closing a stake of 3,924 shares — an estimated $357K sold.

Hartford Investment Management Co (HIMCO) first reported a position in NVO in Q2 2020 and held it in 14 quarters. The position peaked at $640K in Q1 2023. 1,512 funds tracked by Wall St. Rank hold NVO as of Q4 2023.

  • Hartford Investment Management Co (HIMCO) reported no remaining Novo Nordisk position as of Q4 2023 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 3,924 Novo Nordisk shares in Q4 2023, an estimated $357K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Novo Nordisk in Q2 2020 and held it in 14 quarters.
  • Hartford Investment Management Co (HIMCO)'s Novo Nordisk position peaked at $640K in Q1 2023.
  • 1,512 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2023.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q4 2023, filed 23 Jan 2024.